| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 04/09/2014 | CN103709180A Polycyclic aromatic hydrocarbon derivative containing imidazo [1, 2, a] pyridine group and application thereof in OLED |
| 04/09/2014 | CN103709162A Tri-substituted imidazo diazanaphthalene ketone compounds, preparation method thereof and applications thereof |
| 04/09/2014 | CN103709161A One-dimensional organic semiconductor nanowire with fluorescence and photoconduction dual response for organic amine gas as well as preparation method and application of nanowire |
| 04/09/2014 | CN103709160A Alzheimer's disease prevention and treatment medicine and preparation method thereof |
| 04/09/2014 | CN103709159A Preparation method of 4,5-diazafluoren-9-alcohol and Friedel-Craft reaction post-modification material thereof |
| 04/09/2014 | CN103709158A Pyrazolopyrimidine ureas compound and application thereof |
| 04/09/2014 | CN103709138A 5-(fluoroquinolone C3- methylene)3-pyrrolic amide derivative as well as preparation method and application thereof |
| 04/09/2014 | CN103709122A Antitumor and antifungal compound for treatment |
| 04/09/2014 | CN103709101A Kind of synthesis intermediates of renierramycin G and preparation method of synthesis intermediate |
| 04/09/2014 | CN103706399A Cyclometallated iridium catalyst for reducing nitrogen heterocyclic compounds under mild conditions |
| 04/09/2014 | CN103012375B Pyridyl triazole methyl substituted acridine derivative, preparation method and application thereof |
| 04/09/2014 | CN102603737B Pyridopyrimidine ketones derivative and application in preparing antitumor drugs thereof |
| 04/09/2014 | CN102164919B Oxazolidinyl antibiotics |
| 04/09/2014 | CN101778832B Oxopyrazine derivative and herbicide |
| 04/09/2014 | CN101528704B Serine-threonine protein kinase and PARP modulators |
| 04/08/2014 | US8691991 2-oxonaphthyridine-3-carboxamides HIV integrase inhibitors |
| 04/08/2014 | US8691990 6-heterocyclic imidazo[1,2-α]pyridine-2-carboxamide derivatives, preparation and therapeutic use thereof |
| 04/08/2014 | US8691986 Azetidine and piperidine compounds useful as PDE10 inhibitors |
| 04/08/2014 | US8691864 Agents useful for reducing amyloid precursor protein and treating dementia and methods of use thereof |
| 04/08/2014 | US8691837 Substituted imidazo ring systems and methods |
| 04/08/2014 | US8691836 D2 antagonists, methods of synthesis and methods of use |
| 04/08/2014 | US8691814 Deazapurines and uses thereof |
| 04/08/2014 | US8691813 Indole and benzoxazine derivatives as modulators of metabotropic glutamate receptors |
| 04/08/2014 | US8691810 Pyrrolopyridine and pyrrolopyrimidine inhibitors of kinases |
| 04/08/2014 | US8691184 Bcl-2/Bcl-xL inhibitors and therapeutic methods using the same |
| 04/08/2014 | CA2771885C 1,2-dihydro-2-oxoquinoline compounds as 5-ht4receptor ligands |
| 04/08/2014 | CA2641776C Pyrazoloquinolones are potent parp inhibitors |
| 04/08/2014 | CA2621443C Thiophene and thiazole substituted trifluoroethanone derivatives as histone deacetylase (hdac) inhibitors |
| 04/08/2014 | CA2598216C Androgen receptor modulator compounds and methods |
| 04/08/2014 | CA2572047C Octahydropyrrolo[2,3,c]pyridine derivatives and pharmaceutical use thereof |
| 04/08/2014 | CA2563607C 4,5-disubstituted-2-aryl pyrimidines |
| 04/08/2014 | CA2506310C New antagonist derivatives for the vitronectin receptor, their preparation method, their application as medication and the pharmaceutical compositions containing them |
| 04/03/2014 | WO2014052699A1 Azaquinazoline inhibitors of atypical protein kinase c |
| 04/03/2014 | WO2014052365A1 Multiple kinase pathway inhibitors |
| 04/03/2014 | WO2014048939A1 Cyclic ether pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use |
| 04/03/2014 | WO2014048165A1 Compound as potassium channel modulator |
| 04/03/2014 | WO2014024077A9 5-(1H-PYRAZOL-4-YL)-1H-PYRROLO[2,3-b]PYRIDINE DERIVATIVES AS KINASE INHIBITORS |
| 04/03/2014 | WO2014015056A3 Anti-mucus drugs and uses therefor |
| 04/03/2014 | WO2013053983A8 Protein kinase inhibitors |
| 04/03/2014 | US20140094611 Synthesis of heterocyclic compounds |
| 04/03/2014 | US20140094608 Modified carbocyanine dyes and their conjugates |
| 04/03/2014 | US20140094605 Synthesis of carbamoylpyridone hiv integrase inhibitors and intermediates |
| 04/03/2014 | US20140094488 2-amino-3-(imidazol-2-yl)-pyridin-4-one derivatives and their use as vegf receptor kinase inhibitors |
| 04/03/2014 | US20140094487 Dihydro-6-Azaphenalene Derivatives for the Treatment of CNS, Oncological Diseases and Related Disorders |
| 04/03/2014 | US20140094480 Pro-Neurogenic Compounds |
| 04/03/2014 | US20140094474 Androgen receptor modulating carboxamides |
| 04/03/2014 | US20140094473 Inhibitors of influenza viruses replication |
| 04/03/2014 | US20140094471 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
| 04/03/2014 | US20140094456 Anti-fibrotic pyridinones |
| 04/03/2014 | US20140093518 Chemically Programmed Vaccination |
| 04/03/2014 | US20140093505 Pyridonaphthyridine PI3K/MTOR Dual Inhibitors and Preparation and Use Thereof |
| 04/03/2014 | DE102012019369A1 7-Azaindolderivat 7-Azaindolderivat |
| 04/02/2014 | EP2712358A2 Pyrrolidinyl urea, pyrrolidinyl thiourea and pyrrolidinyl guanidine compounds as trka kinase inhibitors |
| 04/02/2014 | EP2712291A1 N1- and n2-carbamoyl-1,2,3-triazole serine hydrolase inhibitors and methods |
| 04/02/2014 | CN103703000A Fused tricyclic dual inhibitors of CDK 4/6 and FLT3 |
| 04/02/2014 | CN103702999A Cyclic p1 linkers as factor xia inhibitors |
| 04/02/2014 | CN103702998A Processes and intermediates for producing azaindoles |
| 04/02/2014 | CN103702990A 2-(2,4,5-substituted -anilino) pyrimidine derivatives as egfr modulators useful for treating cancer |
| 04/02/2014 | CN103694255A Pyridinooxazone-pyridinopyrimidone compounds and preparation method and application thereof |
| 04/02/2014 | CN103694238A NO donor type matrine derivative and preparation method and medical application thereof |
| 04/02/2014 | CN103694237A Preparation method and key intermediate of anticoagulant apixaban |
| 04/02/2014 | CN103694236A Novel antineoplastic compound containing pyrimidine skeleton and hedgehog pathway antagonist activity |
| 04/02/2014 | CN103694163A Compounds capable of being adopted as potassium channel modulators |
| 04/02/2014 | CN102899032B Electropolymerizable fluorescent sensing material and application on fluorescent or electropolymerizable detection of metal ions |
| 04/02/2014 | CN102796166B Glucose-modified 4H-beta-carboline carboxylic acid derivative and preparation method and application thereof |
| 04/02/2014 | CN102712623B Hepatitis c virus inhibitors |
| 04/02/2014 | CN102203094B Novel nitrogenous heterocyclic compounds, preparation thereof and use thereof as antibacterial medicaments |
| 04/02/2014 | CN102046608B 3,4-dihydropyrimidine TRPA1 antagonists |
| 04/02/2014 | CN101346357B Aminodihydrothiazine derivative |
| 04/01/2014 | US8686147 Compound with serotoninergic activity, process for preparing it and pharmaceutical composition comprising it |
| 04/01/2014 | US8686146 Azaindenoisoquinoline topoisomerase I inhibitors |
| 04/01/2014 | US8686144 Condensed pyridine derivatives useful as potent inhibitors of the protein kinase CK2 |
| 04/01/2014 | US8686135 Methods of synthesis and purification of heteroaryl compounds |
| 04/01/2014 | US8686032 Enzyme inhibitors |
| 04/01/2014 | US8686009 Prodrugs of NH-acidic compounds |
| 04/01/2014 | US8686002 Heterocyclic compounds and their use as binding partners for 5-HT5 receptors |
| 04/01/2014 | US8685999 Beta carboline sulphonylurea derivatives as EP4 receptor antagonists |
| 04/01/2014 | US8685997 Camptothecin derivatives and their use |
| 04/01/2014 | US8685995 Treatment with opioid antagonists and mTOR inhibitors |
| 04/01/2014 | US8685969 Carboline carboxamide compounds useful as kinase inhibitors |
| 04/01/2014 | US8685967 Substituted triazolopyridines and analogs thereof |
| 04/01/2014 | US8685664 Use of inhibtors of glutaminyl cyclases for treatment and prevention of disease |
| 04/01/2014 | US8685543 Material for organic electroluminescent devices and organic electroluminescent devices made by using the same |
| 04/01/2014 | CA2654515C Substituted 3-cyanopyridines as protein kinase inhibitors |
| 04/01/2014 | CA2635846C Trisazo compound, ink composition, recording method, and colored article |
| 03/27/2014 | WO2014046589A1 Means and method for treating solid tumours |
| 03/27/2014 | WO2014046392A1 Organic compound and electroluminescent element having same |
| 03/27/2014 | WO2014045305A1 Substituted fused tricyclic compounds, compositions and medicinal applications thereof |
| 03/27/2014 | WO2014045156A1 Novel bicyclic pyridinones |
| 03/27/2014 | WO2014044113A1 Pyrazol[3,4-c] pyridine derivative, preparation method and use in medicine thereof |
| 03/27/2014 | WO2013181579A3 Tetrahydropyrazolopyrimidine compounds |
| 03/27/2014 | US20140088138 Crystalline forms of fused amino pyridines as hsp90 inhibitors |
| 03/27/2014 | US20140088133 Methods and compositions for treating beta-thalassemia and sickle cell disease |
| 03/27/2014 | US20140088124 Imidazole derivatives |
| 03/27/2014 | US20140088122 Method of treatment of age-related macular degeneration (amd) |
| 03/27/2014 | US20140088116 Novel Solid Forms of Antibiotics |
| 03/27/2014 | US20140088114 Fused bicyclic kinase inhibitors |
| 03/27/2014 | US20140088111 Novel Bicyclic Pyridinones |
| 03/27/2014 | US20140088110 Fused bicyclic imidazoles |
| 03/27/2014 | US20140088101 Naphthyridine derivatives as inhibitors of hypoxia inducible factor (hif) hydroxylase |